Hoffwn achub ar y cyfle hwn hefyd i dynnu sylw at ymchwil galonogol iawn yn ymwneud â'r brechlyn HPV. Ers 2008, mae merched 12 neu 13 oed wedi cael cynnig y brechlyn HPV ym mhob rhan o'r DU i'w hamddiffyn rhag canser ceg y groth. Dangosodd ymchwil a gyhoeddwyd yn y British Medical Journal ar 3 Ebrill fod y brechlyn wedi arwain at leihad o 90% mewn celloedd cyn-ganseraidd yn yr Alban.
I would also like to take this opportunity to highlight some very encouraging research relating to HPV vaccination. Since 2008, girls aged 12 or 13 have been offered the HPV vaccine across the UK to protect against cervical cancer. Research published in the British Medical Journal on 3 April showed that in Scotland the vaccine had led to a 90% reduction in pre-cancerous cells.